[Cancer and menopause].
After a brief review of menopausal disorders, the author develops three chapters. The first deals with conventional hormonal or replacement therapy, which has beneficial effects on vasomotor disorders, atrophy of the urogenital tract and osteoporosis, but also carries a risk of adenocarcinoma. Next, the author gives the oncologist's point of view, expounding in particular the major contraindications of estrogen therapy. The third chapter develops non-hormonal treatments of menopause, their specific mode of action and advantages, with a reference to veralipride. In his conclusion, the author emphasizes that hormonal and non-hormonal treatments of menopause should not be opposed but are complementary.
D004967:Estrogens / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008593:Menopause; D009369:Neoplasms / Q000139:chemically induced*; D013469:Sulpiride / Q000031:analogs & derivatives / Q000627:therapeutic use
D004967:Estrogens; D013469:Sulpiride; C027429:veralipride
Cancer et ménopause.